Streptococcus intermedius promotes synchronous multiple primary lung cancer progression through apoptosis regulation
These findings characterize the lung microbiota in sMPLC and identify <i>S. intermedius</i> as a potentially influential bacterial strain. This study provides significant new insights into the diagnosis and treatment of sMPLC.
Authors
- Gong Yang (ORCID: https://orcid.org/0000-0002-5137-4104)
- William Krimsky (ORCID: https://orcid.org/0000-0003-4217-3324)
- Zhong‐Yi Dong (ORCID: https://orcid.org/0000-0001-9967-0060)
- Saiyad Sarkar
- Yong Hang Tai
- Gang Huang (ORCID: https://orcid.org/0000-0002-5457-5358)
- Jun Peng (ORCID: https://orcid.org/0000-0003-2590-0024)
- Kai Qian (ORCID: https://orcid.org/0000-0002-5091-8632)
- Jia Xu (ORCID: https://orcid.org/0000-0002-4379-5347)
- Yi Deng (ORCID: https://orcid.org/0000-0001-5357-5877)
- Hao Peng
Institutions
- Kunming University of Science and Technology (CN)
- Yunnan Normal University (CN)
- MedStar Franklin Square Medical Center (US)
- Sahlgrenska University Hospital (SE)
- First People's Hospital of Yunnan Province (CN)
- University of Gothenburg (SE)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-01-09
- DOI
- https://doi.org/10.3389/fimmu.2024.1482084
- Citations
- 4
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 4.18
Funders
- Kunming Medical University